Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft

Acquired Trastuzumab resistance is a complicated and disastrous event for HER2-positive gastric cancer (GC). In this study, we successfully established a GC PDX model with Trastuzumab sensitivity (176P) and induced a homologous model with acquired Trastuzumab resistance (176R), then comprehensively...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Mengqi, Li, Beifang, Liao, Haiyan, Chen, Zuhua, Huang, Wenwen, Yang, Jing, Ge, Sai, Li, Zhongwu, Shen, Lin, Zhang, Cheng, Gao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719506/
https://www.ncbi.nlm.nih.gov/pubmed/36463209
http://dx.doi.org/10.1038/s41420-022-01259-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719506/
https://www.ncbi.nlm.nih.gov/pubmed/36463209
http://dx.doi.org/10.1038/s41420-022-01259-z

Ejemplares similares